SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001725160-23-000155
Filing Date
2023-08-09
Accepted
2023-08-09 07:06:13
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zntl-20230630.htm   iXBRL 10-Q 1560129
2 EX-10.1 exh101-recuriumxzenoxthird.htm EX-10.1 382710
3 EX-31.1 zentalis10-qq22023ex311.htm EX-31.1 10885
4 EX-31.2 zentalis10-qq22023ex312.htm EX-31.2 11129
5 EX-32.1 zentalis10-qq22023ex321.htm EX-32.1 5587
6 EX-32.2 zentalis10-qq22023ex322.htm EX-32.2 5168
12 image_0.jpg GRAPHIC 614
13 zntl-20230630_g1.jpg GRAPHIC 100929
  Complete submission text file 0001725160-23-000155.txt   7370977

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20230630.xsd EX-101.SCH 38989
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zntl-20230630_cal.xml EX-101.CAL 75001
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20230630_def.xml EX-101.DEF 195675
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20230630_lab.xml EX-101.LAB 595454
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20230630_pre.xml EX-101.PRE 391717
68 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20230630_htm.xml XML 820147
Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39263 | Film No.: 231153332
SIC: 2834 Pharmaceutical Preparations